| # | Drug | Count |
|---|---|---|
| 0 | IMATINIB | 15 |
| 1 | IBUPFROFEN | 14 |
| 2 | IBUPROFEN | 14 |
| 3 | IBUPROFEN 200 MG | 14 |
| 4 | IBUPROFEN 200MG | 14 |
| 5 | IBUPROFEN CAPSULE | 14 |
| 6 | IBUPROFEN CAPSULES 200 MG | 14 |
| 7 | IBUPROFEN ORAL | 14 |
| 8 | IBUPROFEN TABLET, FILM COATED | 14 |
| 9 | IBUPROFEN TABLET, FILM-COATED | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PALOVAROTENE | 10 | 0.1408 |
| 1 | CANAKINUMAB | 1 | 0.0001 |
| 2 | PREDNISOLONE ORAL SOLUTION | 14 | 0.0001 |
| 3 | IMATINIB MESYLATE | 2 | 0.0001 |
| 4 | IBUPFROFEN | 14 | 0.0001 |
| 5 | IBUPROFEN TABLETS USP, 200MG | 14 | 0.0001 |
| 6 | IBUPROFEN ORAL | 14 | 0.0001 |
| 7 | IBUPROFEN CAPSULES 200 MG | 14 | 0.0001 |
| 8 | MONTELUKAST SODIUM | 8 | 0.0001 |
| 9 | ANAKINRA | 1 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 14 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 14 |
| 2 | Retinoid [EPC] | 10 |
| 3 | Leukotriene Receptor Antagonist [EPC] | 8 |
| 4 | Insulin Analog [EPC] | 4 |
| 5 | Alkylating Drug [EPC] | 3 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 3 |
| 7 | Angiotensin 2 Receptor Blocker [EPC] | 1 |
| 8 | Bile Acid [EPC] | 1 |
| 9 | Interleukin-1 Receptor Antagonist [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Leukotriene Receptor Antagonist [EPC] | 8 | 0.0003 |
| 1 | Interleukin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 2 | Bile Acid [EPC] | 1 | 0.0000 |
| 3 | Retinoid [EPC] | 10 | 0.0000 |
| 4 | Alkylating Drug [EPC] | 3 | 0.0000 |
| 5 | Corticosteroid [EPC] | 14 | 0.0000 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 14 | 0.0000 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 3 | 0.0000 |
| 8 | Insulin Analog [EPC] | 4 | 0.0000 |
| 9 | Angiotensin 2 Receptor Blocker [EPC] | 1 | 0.0000 |